First Alzheimer’s Drug in 20 Years Now at DENT

First Alzheimer's Drug

First Alzheimer’s Drug in 20 Years DENT Patients Who Qualify Will Undergo Meticulous Screening By Annette Pinder Aducanumab is the first FDA-approved therapy for Alzheimer’s disease in 20 years, and DENT Neurologic Institute (DENT) is one of the first to administer it. However, eligibility to receive the

Read more

Celebrating 2000th TAVR Procedure

Gates Vascular Institute (GVI) Celebrates Landmark 2000th Transcatheter Heart Valve Procedure (TAVR) TAVR is a minimally invasive treatment option that has revolutionized cardiac medicine and replaced open-heart surgery for many patients Buffalo, N.Y (March 11, 2021) – The structural heart team at Kaleida Health’s Gates Vascular Institute (GVI)

Read more

Ventilator scare prompts UB team to develop low-cost solution

Researchers are working to automate manual resuscitators; could aid sickest COVID-19 patients, developing countries BUFFALO, N.Y. — Spurred by fears of a shortage of ventilators to treat COVID-19 patients, University at Buffalo researchers are developing a low-cost solution using a common medical device. The device is a

Read more